Literature DB >> 30601329

Small Numbers of CD4+ T Cells Can Induce Development of Lymphedema.

Catherine L Ly1, Daniel A Cuzzone1, Raghu P Kataru1, Babak J Mehrara1.   

Abstract

BACKGROUND: CD4 T cells have been implicated in the pathology of lymphedema. Interestingly, however, there have been case reports of lymphedema development in patients with low levels of CD4 T cells because of immunosuppression. In this study, the authors sought to delineate the effect of relative CD4 T-cell deficiency on the development of lymphedema in a mouse model.
METHODS: A mouse model of relative CD4 T-cell deficiency was created through lethal total body irradiation of wild-type mice that then underwent bone marrow transplantation with progenitors harvested from CD4 knockout mice (wild-type/CD4 knockout). Irradiated CD4 knockout mice reconstituted with wild-type mouse-derived progenitors (CD4 knockout/wild-type), and unirradiated CD4 knockout and wild-type mice were used as controls. All mice underwent tail skin and lymphatic excision to induce lymphedema, and analysis was performed 6 weeks later.
RESULTS: Wild-type/CD4 knockout chimeras were not protected from developing lymphedema. Despite a global deficit in CD4 T cells, these mice had swelling, fibrosis, inflammation, and impaired lymphatic transport function indistinguishable from that in wild-type and CD4 knockout/wild-type mice. In contrast, unirradiated CD4 knockout mice had no features of lymphedema after lymphatic injury.
CONCLUSIONS: Relatively small numbers of bone marrow and peripheral CD4 T cells are sufficient to induce the development of lymphedema. These findings suggest that lymphatic injury results in expansion of CD4 T-cell populations in lymphedematous tissues.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30601329      PMCID: PMC6395505          DOI: 10.1097/PRS.0000000000005322

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  26 in total

1.  Risk factors for lymphedema in a prospective breast cancer survivorship study: the Pathways Study.

Authors:  Marilyn L Kwan; Jeanne Darbinian; Kathryn H Schmitz; Rebecca Citron; Paula Partee; Susan E Kutner; Lawrence H Kushi
Journal:  Arch Surg       Date:  2010-11

2.  The risk of developing arm lymphedema among breast cancer survivors: a meta-analysis of treatment factors.

Authors:  Rebecca J Tsai; Leslie K Dennis; Charles F Lynch; Linda G Snetselaar; Gideon K D Zamba; Carol Scott-Conner
Journal:  Ann Surg Oncol       Date:  2009-04-14       Impact factor: 5.344

Review 3.  The diagnosis and treatment of peripheral lymphedema: 2013 Consensus Document of the International Society of Lymphology.

Authors: 
Journal:  Lymphology       Date:  2013-03       Impact factor: 1.286

4.  Regulatory T Cells Mediate Local Immunosuppression in Lymphedema.

Authors:  Gabriela D García Nores; Catherine L Ly; Ira L Savetsky; Raghu P Kataru; Swapna Ghanta; Geoffrey E Hespe; Stanley G Rockson; Babak J Mehrara
Journal:  J Invest Dermatol       Date:  2017-09-20       Impact factor: 8.551

5.  Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET.

Authors:  Héctor Peinado; Maša Alečković; Simon Lavotshkin; Irina Matei; Bruno Costa-Silva; Gema Moreno-Bueno; Marta Hergueta-Redondo; Caitlin Williams; Guillermo García-Santos; Cyrus Ghajar; Ayuko Nitadori-Hoshino; Caitlin Hoffman; Karen Badal; Benjamin A Garcia; Margaret K Callahan; Jianda Yuan; Vilma R Martins; Johan Skog; Rosandra N Kaplan; Mary S Brady; Jedd D Wolchok; Paul B Chapman; Yibin Kang; Jacqueline Bromberg; David Lyden
Journal:  Nat Med       Date:  2012-06       Impact factor: 53.440

6.  TGF-beta1 is a negative regulator of lymphatic regeneration during wound repair.

Authors:  Nicholas W Clavin; Tomer Avraham; John Fernandez; Sanjay V Daluvoy; Marc A Soares; Arif Chaudhry; Babak J Mehrara
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-10-10       Impact factor: 4.733

Review 7.  Lower extremity lymphedema caused by acquired immune deficiency syndrome-related Kaposi's sarcoma: case report and review of the literature.

Authors:  P J Allen; D L Gillespie; R R Redfield; E R Gomez
Journal:  J Vasc Surg       Date:  1995-08       Impact factor: 4.268

8.  Th2 differentiation is necessary for soft tissue fibrosis and lymphatic dysfunction resulting from lymphedema.

Authors:  Tomer Avraham; Jamie C Zampell; Alan Yan; Sonia Elhadad; Evan S Weitman; Stanley G Rockson; Jacqueline Bromberg; Babak J Mehrara
Journal:  FASEB J       Date:  2012-11-27       Impact factor: 5.191

9.  Risk factors and a prediction model for lower limb lymphedema following lymphadenectomy in gynecologic cancer: a hospital-based retrospective cohort study.

Authors:  Kenji Kuroda; Yasuhiro Yamamoto; Manami Yanagisawa; Akira Kawata; Naoya Akiba; Kensuke Suzuki; Kazutoshi Naritaka
Journal:  BMC Womens Health       Date:  2017-07-25       Impact factor: 2.809

10.  Early specification of CD8+ T lymphocyte fates during adaptive immunity revealed by single-cell gene-expression analyses.

Authors:  Janilyn Arsenio; Boyko Kakaradov; Patrick J Metz; Stephanie H Kim; Gene W Yeo; John T Chang
Journal:  Nat Immunol       Date:  2014-03-02       Impact factor: 25.606

View more
  5 in total

Review 1.  Lymphatic Valves and Lymph Flow in Cancer-Related Lymphedema.

Authors:  Drishya Iyer; Melanie Jannaway; Ying Yang; Joshua P Scallan
Journal:  Cancers (Basel)       Date:  2020-08-15       Impact factor: 6.639

Review 2.  Pharmacological Treatment of Secondary Lymphedema.

Authors:  Stav Brown; Joseph H Dayan; Michelle Coriddi; Adana Campbell; Kevin Kuonqui; Jinyeon Shin; Hyeung Ju Park; Babak J Mehrara; Raghu P Kataru
Journal:  Front Pharmacol       Date:  2022-01-25       Impact factor: 5.810

Review 3.  Emerging Anti-Inflammatory Pharmacotherapy and Cell-Based Therapy for Lymphedema.

Authors:  Ryohei Ogino; Tomoharu Yokooji; Maiko Hayashida; Shota Suda; Sho Yamakawa; Kenji Hayashida
Journal:  Int J Mol Sci       Date:  2022-07-09       Impact factor: 6.208

Review 4.  Current Advancements in Animal Models of Postsurgical Lymphedema: A Systematic Review.

Authors:  Jerry F Hsu; Roy P Yu; Eloise W Stanton; Jin Wang; Alex K Wong
Journal:  Adv Wound Care (New Rochelle)       Date:  2021-08-27       Impact factor: 4.947

Review 5.  Histopathologic Features of Lymphedema: A Molecular Review.

Authors:  Claire Y Li; Raghu P Kataru; Babak J Mehrara
Journal:  Int J Mol Sci       Date:  2020-04-06       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.